top of page

Research Projects

logo TBMED.png

Call: H2020-NMBP-TO-IND 

Budget: 8 480 543 €

(503 000 € UNIZAR)

2019-2023

PI UNIZAR: Raluca Fratila

h2020.jpg

TBMED -An Open Innovation test bed for the development of high-risk medical devices

​

TBMED aims to develop an Open Innovation Test Bed (OITB) for high risk medical devices that provides a single entry point to services along the whole value chain from preclinical development to clinical testing. The entire development will be based on a Quality-by-Design (QbD) concept.

In TBMED, we work on the development of a synergistic magnetic hyperthermia-chemotherapy approach for pancreatic cancer treatment. A new manufacturing process of magnetic nanoparticles is being developed using the QbD approach, based on more reproducible and easily scalable methods in order to validate the manufacturing process to regulatory requirements.   

Logo MCG-v2.png

Call: M-ERA.NET 2016

Budget: 337.313 €

2017-2021

PI : Valeria Grazú

meranet-logo.jpg
Captura de pantalla 2021-01-24 a las 17.

MagicCELLGene - Localized MAGnetiC hyperthermia CELL-based GENE therapy for immune modulation

 

The goal of MagicCELLGene is to develop a novel, universal and highly efficient methodology for transfection triggered by magnetic hyperthermia, with potential clinical applications in cell-based gene therapy. Our innovative approach is to induce a controlled and localized heating of the cellular membrane (hotspots) using magnetic nanoparticles covalently immobilized onto cell membranes via bioorthogonal chemistry; the reversible changes of the cell membrane permeability/fluidity will be used to promote the artificial delivery of nucleic acids into cells. Efforts will be especially focused on hard-to-transfect cells (primary cells), thus clearly addressing an unmet need of the transfection market. Expected results going beyond the state-of-the-art in transfection are: i) the development of a universal transfection tool and ii) its application to systems where standard transfection methods have several bottlenecks using as a model immune system modulation.​   

Captura de pantalla 2021-01-24 a las 17.

Call: PGC 2018

Budget: 72 600 €

2019-2022

PI : Raluca Fratila & Lucía Gutiérrez

logo_mciu.png
AEI-solo-01-apaisado_250X250.jpg
FEDER.png

MACBETH - Magnetic nanoparticles for cell membrane hyperfluidization with localized hyperthermia

​

With the MACBETH project, we aim at generating a protocol to modify the cell membrane fluidity through the use of magnetic nanoparticles (MNPs) covalently bound to the cell membrane and remotely activated by alternating magnetic fields (magnetic hyperthermia, MH) or near infrared light (optical hyperthermia, OH). This approach will allow us to:

1) Explore the different hyperthermia approaches (either MH or OH) as tools for the

hyperfluidization of the cellular membrane of living cells;

2) Study the effect that this increased cell membrane fluidity has on the cellular internalization of MNPs, both in terms of efficiency and intracellular localization of the MNPs.

3) Evaluate the cell membrane hyperfluidization as a potential tool for enhancing cellular uptake of MNPs in tumoral cells with low MNP internalization in normal conditions.

h2020.jpg
MC actions.jpg

Call: MSCA-IF-2014

Budget: 158 121 €

2015-2017

PI : Raluca Fratila

OUTstandINg - Cell-surface immobilized vs. internalized magnetic nanoparticles for magnetic hyperthermia studies

​

The MSC OUTstandINg project will use bioorthogonal click chemistry as tool to covalently attach magnetic nanoparticles (MNPs) to living cell surfaces with the aim to address two fundamental questions in the field of magnetic hyperthermia therapy using MNPs: 1) how the subcellular localization (on the plasma membrane or inside the cells) of MNPs affects their heating behaviour when compared to MNPs in solution 2) how MNPs immobilization and sub-lethal magnetic hyperthermia impact different subcellular signalling pathways and the biophysics of cell membranes. 
OUTstandINg is a multidisciplinary two-years research project built upon the expertise of the Fellow (Dr. Raluca M. Fratila) in bioorganic chemistry (including click chemistry, bioconjugates and functionalization of surfaces and (nano)materials) and the experience of the supervisor (Dr. Jesús Martínez de la Fuente) and of the host group (GN2 - Nanotherapy and Nanobiosensors, University of Zaragoza, Spain) in nanotechnology and nanomedicine. This MSC action will offer the Fellow the possibility to work in one of the top European institutions in nanoscience, where she will further develop her skills and will acquire new skills and knowledge necessary for the progress of her scientific career towards an independent position. The secondment period at University College London Institute for Biomedical Engineering (supervisor Prof. Quentin Pankhurst) will reinforce and complete the multidisciplinary training-through-research. The project will generate important knowledge and collaborations in the European Research Area (ERA) and will contribute to enhance the excellence of ERA through cutting-edge research at the frontier of chemistry, physics, materials science, cell biology and nanotechnology.

bottom of page